| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e80c7b2f3a331cc1f3bf2d6715efab4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-27 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate |
2021-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_deda24e91a265882da9f326083afd548
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4776ef56740230e11d1a6a47ba14069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e4e2829b18cd3735b9f681642f9df56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0980324a631ed205ca18e25eb20d503 |
| publicationDate |
2021-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EC-SP21040300-A |
| titleOfInvention |
SYNERGIC COMPOSITIONS INCLUDING (R) -2- (2-OXOPYRROLIDIN-1-IL) BUTANAMIDE AND (S) -2- (2-OXOPYRROLIDIN-1-IL) BUTANAMIDE IN A NON-RACEMIC PROPORTION |
| abstract |
The present invention relates to a composition of the enantiomers of 2- (2-oxopyrrolidin-1-yl) butanamide and pharmaceutically acceptable solvates or co-crystals thereof in a certain proportion, a pharmaceutical composition comprising said composition, its use as a medicament and the use of the inventive pharmaceutical compositions or compositions in the treatment and / or prevention of a generally and preferably selected disease or disorder of seizure-related disorders, peripheral sensory neuropathy, preferably peripheral neuropathic pain; seizures; depression; or cognitive impairment. |
| priorityDate |
2018-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |